Novartis moving UK HQ to London

Gilead & insitro using machine learning for novel NASH therapies
Credit: ESB Professional

Novartis has revealed it is moving its UK headquarters to London in what’s it’s hailing as a multi-million-pound investment in the UK life sciences sector.

By January 2020, the company’s new UK base will be The WestWorks, White City, which is home to several technology and innovation companies.

White City Place is emerging to be London’s latest life sciences cluster. It is quickly becoming home to a number of pioneering life sciences companies at the forefront of innovation, as well as Imperial College London’s major new research and innovation campus at White City.

The campus co-locates multidisciplinary research with global businesses, new start-ups and fast-growth technology companies on an unprecedented scale.

“The nature of healthcare and medicine is changing and as we pivot towards becoming a focused medicines company, powered by digital and data, we want to be closer to our customers and partners, and become better networked in the healthcare and life science ecosystem.” said Haseeb Ahmad, Novartis UK Country President.

“White City is quickly becoming one of the UK’s life sciences and technology districts, and the ethos of The WestWorks campus complements how we work to deliver on our strategy to reimagine medicine.”